These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18664689)

  • 1. Parameters to maximize 2f2-f1 distortion product otoacoustic emission levels.
    Horn JH; Pratt SR; Durrant JD
    J Speech Lang Hear Res; 2008 Dec; 51(6):1620-9. PubMed ID: 18664689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
    Dreisbach LE; Long KM; Lees SE
    Ear Hear; 2006 Oct; 27(5):466-79. PubMed ID: 16957498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
    Johnson TA; Baranowski LG
    Ear Hear; 2012; 33(2):239-49. PubMed ID: 21918451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus of generation for the 2f1-f2 vs 2f2-f1 distortion-product otoacoustic emissions in normal-hearing humans revealed by suppression tuning, onset latencies, and amplitude correlations.
    Martin GK; Jassir D; Stagner BB; Whitehead ML; Lonsbury-Martin BL
    J Acoust Soc Am; 1998 Apr; 103(4):1957-71. PubMed ID: 9566319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative distortion product otoacoustic emissions and hearing loss in a clinical population.
    Lind O
    Scand Audiol; 1999; 28(4):257-61. PubMed ID: 10572971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human efferent adaptation of DPOAEs in the L1,L2 space.
    Meinke DK; Stagner BB; Martin GK; Lonsbury-Martin BL
    Hear Res; 2005 Oct; 208(1-2):89-100. PubMed ID: 16019174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase delay measurements of distortion product otoacoustic emissions at 2f1-f2 and 2f2-f1 in human ears.
    Wable J; Collet L; Chéry-Croze S
    J Acoust Soc Am; 1996 Oct; 100(4 Pt 1):2228-35. PubMed ID: 8865631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-retest repeatability of distortion product otoacoustic emissions.
    Wagner W; Heppelmann G; Vonthein R; Zenner HP
    Ear Hear; 2008 Jun; 29(3):378-91. PubMed ID: 18382378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distortion product otoacoustic emission (2f1-f2) amplitude as a function of f2/f1 frequency ratio and primary tone level separation in human adults and neonates.
    Abdala C
    J Acoust Soc Am; 1996 Dec; 100(6):3726-40. PubMed ID: 8969474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion product otoacoustic emission response characteristics in older adults.
    Torre P; Cruickshanks KJ; Nondahl DM; Wiley TL
    Ear Hear; 2003 Feb; 24(1):20-9. PubMed ID: 12598810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Otoacoustic distortion products in adults with normal hearing].
    Simoncelli C; Molini E; Ricci G; Capolunghi B; Alunni N
    Acta Otorhinolaryngol Ital; 1995 Apr; 15(2):80-6. PubMed ID: 8928654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the 2f
    Wen H; Bowling T; Meaud J
    Hear Res; 2018 Aug; 365():127-140. PubMed ID: 29801982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine alterations of distortion-product otoacoustic emissions after moderate acoustic overexposure in guinea pigs.
    Kossowski M; Mom T; Guitton M; Poncet JL; Bonfils P; Avan P
    Audiology; 2001; 40(3):113-22. PubMed ID: 11465293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of short-term tone exposure on DPOAEs].
    Shi Y; Jiang S; Gu R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Feb; 32(1):41-4. PubMed ID: 10743127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicomponent acoustic distortion product otoacoustic emission phase in humans. II. Implications for distortion product otoacoustic emissions generation.
    Moulin A; Kemp DT
    J Acoust Soc Am; 1996 Sep; 100(3):1640-62. PubMed ID: 8817892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.